In advanced PACG eyes with 360° angle closure, the differences between the 12-month IOP control, surgical success, and medication reduction of the two groups.

Explore All 2004 Winners & Awards > Charles D. KelmanNew York Medical College For revolutionizing the surgical removal of cataracts, turning a 10-day hospital stay with high morbidity…

A 55-year-old male patient diagnosed with age-related cataract underwent phacoemulsification and intraocular lens implantation. The surgical procedure was performed using an innovative prototype digital navigation microscope (TowardPi Medical Technology…

YouTube video by EyeSmart — American Academy of Ophthalmology

ORLANDO — Performing phacoemulsification with lower infusion pressure was beneficial for patients, according to a poster presented at the American Academy of Ophthalmology meeting. In a study, patients were randomly assigned to undergo surgery with an infusion pressure of 28 mm Hg in one eye and 65 mm Hg in the fellow eye. {{VIDEO}} “We looked at intraoperative events like the use of phacoemulsification, and it turns out that the cumulative dissipated energy, CDE, was significantly less when we used lower infusion pressure,” Healio | OSN Associate Medical Editor John A. Hovanesian, MD, FACS, of

Yet another routine, real time, modern cataract surgery employing a temporal, clear-corneal, sutureless approach and phacoemulsification with implantation of...

Background: Cataract remains the leading cause of reversible blindness worldwide, particularly in older adults, in whom capsular weakness during phacoemulsification may preclude posterior chamber intraocular lens (IOL) implantation. In such scenarios, alternative fixation methods such as scleral-sutured and iris-claw lenses are preferred. However, direct comparative evidence regarding their safety, stability, and postoperative visual outcomes during primary cataract surgery is limited. Objective: This #Study aims to compare the surgical and visual outcomes between retropupillary iris-claw IOL implantation and scleral-sutured fixation of single-piece foldable IOLs performed during primary cataract surgery by phacoemulsification in patients with inadequate capsular support. Methods: This is a prospective, 2-arm, open-label #RCT #ClinicalTrial being conducted at the Department of Ophthalmology, Acharya Vinoba Bhave Rural Hospital, Sawangi, India. A total of 92 patients aged 35 to 75 years with intraoperative posterior capsular compromise will be randomized (block randomization, sealed opaque envelopes) into 2 groups: group A (retropupillary iris-claw IOL) and group B (scleral-sutured IOL). Preoperative, intraoperative, and postoperative data will be collected at day 1, day 15, day 30, and day 90. The primary outcomes are best-corrected visual acuity and lens-induced astigmatism at 3 months. Secondary outcomes include IOL centration or tilt, intraoperative and postoperative complications, and patient satisfaction (assessed using the National Eye Institute Visual Function Questionnaire-25). Data will be analyzed using ANOVA and mixed-effects models. Results: Recruitment commenced in March 2025 and is expected to conclude by September 2025, with interim data analysis scheduled for November 2025. As of the current submission, patient enrollment is ongoing, and no interim results have been analyzed. Conclusions: This randomized #Protocol is designed to generate comparative clinical evidence on the efficacy, safety, and visual stability of iris-claw and scleral-sutured IOL fixation in primary cataract surgery. The findings will contribute to optimizing surgical decision-making in cases with deficient posterior capsular support. Trial Registration: Clinical Trial Registry — India CTRI/2025/03/083687; https://tinyurl.com/bdexxmjy International Registered Report Identifier (IRRID): PRR1-10.2196/80943

Exploring the significance of changes in anterior chamber depth (ΔACD) and astigmatism between 4 & 8 weeks following uneventful phacoemulsification.

To determine if changes in UCDVA, UCIVA, UCNVA, and low-contrast CDVA (10% & 25%) post-phacoemulsification with PCIOLs are linked to preoperative HOA values.

Intraoperative floppy iris syndrome is a clinical situation encountered during phacoemulsification characterized by loss of iris muscle tone, predominantly seen in patients on alpha-1 receptor antagonist medication. The floppiness of the iris tissue along with constant billowing into the corneal incision is a surgical challenge. The iris tissue in intraoperative floppy iris syndrome (IFIS) behaves differently compared with a normal iris. As the dexterity of the iris tissue is lost, it tends to remain updrawn toward the corneal incision or side-port incision. The corneal wound acts as a pressure

Intraoperative floppy iris syndrome is a clinical situation encountered during phacoemulsification characterized by loss of iris muscle tone, predominantly seen in patients on alpha-1 receptor antagonist medication. The floppiness of the iris tissue along with constant billowing into the corneal incision is a surgical challenge. The iris tissue in intraoperative floppy iris syndrome (IFIS) behaves differently compared with a normal iris. As the dexterity of the iris tissue is lost, it tends to remain updrawn toward the corneal incision or side-port incision. The corneal wound acts as a pressure